Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beam Therapeutics (BEAM) Tax Provisions (2022 - 2024)

Beam Therapeutics (BEAM) has disclosed Tax Provisions for 3 consecutive years, with $39000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Tax Provisions changed N/A to $39000.0 in Q2 2024 year-over-year; TTM through Mar 2025 was $39000.0, a 98.38% decrease, with the full-year FY2024 number at $39000.0, down 97.21% from a year prior.
  • Tax Provisions was $39000.0 for Q2 2024 at Beam Therapeutics, down from $1.4 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.4 million in Q3 2022 to a low of $39000.0 in Q2 2024.
  • A 3-year average of $1.2 million and a median of $1.2 million in 2022 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 38.61% in 2023; the steepest drop was 38.61% in 2023.
  • Beam Therapeutics' Tax Provisions stood at $1.0 million in 2022, then surged by 38.61% to $1.4 million in 2023, then crashed by 97.21% to $39000.0 in 2024.
  • Per Business Quant, the three most recent readings for BEAM's Tax Provisions are $39000.0 (Q2 2024), $1.4 million (Q4 2023), and $1.0 million (Q4 2022).